Cargando…
Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression
INTRODUCTION: One of the most pressing goals for cancer immunotherapy at this time is the identification of actionable antigens. METHODS: This study relies on the following considerations and approaches to identify potential breast cancer antigens: (i) the significant role of the adaptive immune rec...
Autores principales: | Pakasticali, Nagehan, Chobrutskiy, Andrea, Patel, Dhruv N., Hsiang, Monica, Zaman, Saif, Cios, Konrad J., Blanck, George, Chobrutskiy, Boris I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259117/ https://www.ncbi.nlm.nih.gov/pubmed/37313373 http://dx.doi.org/10.1177/11769351231177269 |
Ejemplares similares
-
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates
por: Hsiang, Monica, et al.
Publicado: (2021) -
Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression
por: Arias, Miguel A., et al.
Publicado: (2023) -
Erratum to “Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression”
Publicado: (2023) -
An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen
por: Cheng, Peter, et al.
Publicado: (2023) -
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemia
por: Diviney, Andrea, et al.
Publicado: (2019)